Key result
Highest TyG-BMI linked to ~28% higher all-cause mortality vs Q2 in U-shaped pattern.
Why the study?
Are triglyceride-glucose index (TyG) and TyG-related indicators associated with all-cause mortality and life expectancy in middle-aged and older primary care patients?
Cross-Sectional (n=10,688)
Yes
Are triglyceride-glucose index (TyG) and TyG-related indicators associated with all-cause mortality and life expectancy in middle-aged and older primary care patients?
Answers are grounded in this paper and cite their sources.
TyG-BMI and TyG-WC show a U-shaped association with all-cause mortality and reduced life expectancy in middle-aged and older primary care patients.
Background: Insulin resistance (IR) is an important risk factor for multiple chronic diseases, increasing mortality and reducing life expectancy. The associations between emerging surrogates for IR, triglyceride-glucose index (TyG) and TyG-related indicators, with all-cause mortality and life expectancy in middle-aged and older patients in primary care are unclear. Methods: This study originated from the Polish primary care cohort LIPIDOGRAM2015, including patients aged ≥45 years. Baseline fasting triglycerides and fasting glucose were used to derive TyG. Other TyG-related indicators included TyG-adjusted body mass index (TyG-BMI), TyG-adjusted waist circumference (TyG-WC), TyG-adjusted waist-to-hip, and TyG-adjusted waist-to-height. In this longitudinal analysis, we assessed associations between TyG-related indicators with total all-cause mortality, premature (age at death ≤75 years) all-cause mortality and years of life lost (YLL). Findings: We included 10,688 patients (mean age 61.8 ± 9.3 years; 63.5% female). Cumulative total and premature all-cause mortality were 7.2% and 4.6%, respectively, during 5.7 years (IQR 5.6-5.7) of follow-up. Lowest (Q1) and highest quartile (Q4) of TyG-BMI and TyG-WC were associated with total all-cause mortality (second quartile [Q2]: reference; TyG-BMI: Q1: aHR 1.33, 95% CI 1.07-1.65, Q4: aHR 1.28, 95% CI 1.03-1.58; TyG-WC: Q1: aHR 1.44, 95% CI 1.14-1.82, Q4: aHR 1.29, 95% CI 1.04-1.59), similar results for premature all-cause mortality. Within age 45-80 years, compared with Q2 and third quartile, YLL were 4.49 and 5.46 years for TyG-BMI Q1 and Q4, respectively, 3.24 and 5.31 years for TyG-WC Q1 and Q4, respectively. Interpretation: TyG-BMI and TyG-WC demonstrated a U-shaped association with total and premature all-cause mortality. Low and high levels of TyG-BMI and TyG-WC were associated with reduced life expectancy. Despite the relatively short follow-up period, significant associations were still observed, but longer follow-up studies are required to further explore these relationships.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2024) conducted a cross-sectional in Primary care patients (n=10,688). TyG-BMI and TyG-WC (surrogates for insulin resistance) vs. Second quartile (Q2) was evaluated on Total all-cause mortality (aHR 1.28, 95% CI 1.03-1.58). High and low levels of TyG-BMI and TyG-WC demonstrated a U-shaped association with increased all-cause mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: